Literature DB >> 1326584

Detection of varicella-zoster virus DNA in the oropharynx and blood of patients with varicella.

M H Sawyer1, Y N Wu, C J Chamberlin, C Burgos, S K Brodine, W A Bowler, A LaRocco, E C Oldfield, M R Wallace.   

Abstract

The polymerase chain reaction (PCR) was used to detect varicella-zoster virus (VZV) DNA in respiratory epithelial cells and in peripheral blood leukocytes from adults with varicella. VZV DNA was detected in oropharyngeal epithelium in 62% of patients early in the course of varicella; the amount of VZV DNA declined with time and was detectable in only 22% of patients for greater than 6 days. VZV DNA was also detected in peripheral blood leukocytes in 74% of patients early in disease and was detected in both polymorphonuclear and mononuclear leukocytes. PCR demonstrated the presence of VZV DNA in the oropharynx and blood of most patients during varicella, in contrast to the ability to detect VZV in these tissues by viral culture.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326584     DOI: 10.1093/infdis/166.4.885

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Varicella zoster infection in HIV-infected children.

Authors:  C Rongkavilit; C D Mitchell; S Nachman
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.022

2.  Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates.

Authors:  W Soong; J C Schultz; A C Patera; M H Sommer; J I Cohen
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Varicella-zoster virus proteins in skin lesions: implications for a novel role of ORF29p in chickenpox.

Authors:  P W Annunziato; O Lungu; C Panagiotidis; J H Zhang; D N Silvers; A A Gershon; S J Silverstein
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Quantitation of varicella-zoster virus DNA in whole blood, plasma, and serum by PCR and electrochemiluminescence.

Authors:  M D de Jong; J F Weel; T Schuurman; P M Wertheim-van Dillen; R Boom
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

5.  Reactivation of chickenpox contracted in infancy.

Authors:  K Terada; S Kawano; Y Hiraga; T Morita
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

6.  Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers.

Authors:  Chia-Chi Ku; Jorge A Padilla; Charles Grose; Eugene C Butcher; Ann M Arvin
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 7.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

Review 8.  Varicella-zoster virus.

Authors:  A M Arvin
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

9.  Inhibition of PCR by aqueous and vitreous fluids.

Authors:  D L Wiedbrauk; J C Werner; A M Drevon
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

10.  Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice.

Authors:  J F Moffat; M D Stein; H Kaneshima; A M Arvin
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.